Genomic complexity of multiple myeloma and its clinical implications
10.1038/nrclinonc.2016.122 · 2017
The recurrent IgH translocations are highly associated with nonhyperdiploid variant multiple myeloma
10.1182/blood-2003-02-0493 · 2003
Hypodiploidy is a major prognostic factor in multiple myeloma
10.1182/blood.v98.7.2229 · 2001
Prognostic factors for hyperdiploid‐myeloma: effects of chromosome 13 deletions and IgH translocations
10.1038/sj.leu.2404172 · 2006
Coexistent hyperdiploidy does not abrogate poor prognosis in myeloma with adverse cytogenetics and may precede IGH translocations
10.1182/blood-2014-07-584268 · 2015
IMWG consensus on risk stratification in multiple myeloma
10.1038/leu.2013.247 · 2014
Second revision of the international staging system (R2‐ISS) for overall survival in multiple myeloma: a European myeloma network (EMN) report within the HARMONY project
10.1200/jco.21.02614 · 2022
Identification of novel mutational drivers reveals oncogene dependencies in multiple myeloma
10.1182/blood-2018-03-840132 · 2018
Chromosome 1q21 abnormalities in multiple myeloma
10.1038/s41408-021-00474-8 · 2021
Identification of the true hyperdiploid multiple myeloma subset by combining conventional karyotyping and FISH analysis
10.1038/s41408-020-0285-6 · 2020
Cytogenetic classification in Korean multiple myeloma patients: prognostic significance of hyperdiploidy with 47‐50 chromosomes and the number of structural abnormalities
10.1111/ejh.12257 · 2014
Clinical features and treatment outcome in newly diagnosed Chinese patients with multiple myeloma: results of a multicenter analysis
10.1038/bcj.2014.55 · 2014
International myeloma working group updated criteria for the diagnosis of multiple myeloma
10.1016/s1470-2045(14)70442-5 · 2014
Trisomies in multiple myeloma: impact on survival in patients with high‐risk cytogenetics
10.1182/blood-2011-11-390658 · 2012
High‐resolution genomic profiles define distinct clinico‐pathogenetic subgroups of multiple myeloma patients
10.1016/j.ccr.2006.03.019 · 2006
Comprehensive molecular profiling of multiple myeloma identifies refined copy number and expression subtypes
10.1038/s41588-024-01853-0 · 2024
Genomic analysis of multiple myeloma using targeted capture sequencing in the Japanese cohort
10.1111/bjh.16720 · 2020
Chromosome abnormalities clustering and its implications for pathogenesis and prognosis in myeloma
10.1038/sj.leu.2402797 · 2003
Molecular dissection of hyperdiploid multiple myeloma by gene expression profiling
10.1158/0008-5472.can-06-4046 · 2007
Understanding the role of hyperdiploidy in myeloma prognosis: which trisomies really matter?
10.1182/blood-2015-06-650242 · 2015
Somatic mutations of the histone H3K27 demethylase gene UTX in human cancer
10.1038/ng.349 · 2009
Expression of the FOXP1 transcription factor is strongly associated with inferior survival in patients with diffuse large B‐cell lymphoma
10.1158/1078-0432.1065.11.3 · 2005
Concomitant gain of 1q21 and MYC translocation define a poor prognostic subgroup of hyperdiploid multiple myeloma
10.3324/haematol.2015.136929 · 2016
Frequent translocation t(4;14)(p16.3;q32.3) in multiple myeloma is associated with increased expression and activating mutations of fibroblast growth factor receptor 3
10.1038/ng0797-260 · 1997
Cereblon‐binding proteins expression levels correlate with hyperdiploidy in newly diagnosed multiple myeloma patients
10.1038/s41408-019-0174-z · 2019
MYC dysregulation in the progression of multiple myeloma
10.1038/s41375-019-0543-4 · 2020
Temporal genomic dynamics shape clinical trajectory in multiple myeloma
10.1038/s41588-025-02292-1 · 2025
